Table 3. Hazard ratios of Osteoporosis between all gastric disease patients with early HP Eradication and with late HP Eradication stratified by demographic characteristics and comorbidity.
Early HP Eradication | Late HP Eradication | |||
---|---|---|---|---|
IRR* | Adjusted HR† | IRR* | Adjusted HR† | |
(95% CI) | (95% CI) | (95% CI) | (95% CI) | |
All | 1 (Reference) | 1 (Reference) | 1.61 (1.38, 1.89)*** | 1.11 (0.85, 1.46) |
Gender | ||||
Female | 1 (Reference) | 1 (Reference) | 1.44 (1.13, 1.84)** | 1.11 (0.79, 1.57) |
Men | 1 (Reference) | 1 (Reference) | 1.81 (1.48, 2.22)*** | 1.02 (0.66, 1.58) |
Age | ||||
≤49 | 1 (Reference) | 1 (Reference) | 1.40 (1.09, 1.79)** | 1.15 (0.59, 2.22) |
≥50 | 1 (Reference) | 1 (Reference) | 1.28 (1.04, 1.57)* | 1.10 (0.82, 1.48) |
Comorbidity‡ | ||||
No | 1 (Reference) | 1 (Reference) | 1.30 (1.07, 1.59)** | 1.05 (0.72, 1.53) |
Yes | 1 (Reference) | 1 (Reference) | 1.35 (1.04, 1.77)* | 1.09 (0.75, 1.60) |
IRR*, incidence rate ratio; Adjusted HR†, multiple analysis including age, sex, and co-morbidities of CAD, alcohol-related illness, stroke, COPD, asthma, rheumatoid arthritis; Comorbidity‡: Only to have one of comorbidities (including CAD, alcohol-related illness, stroke, COPD, asthma, rheumatoid arthritis) classified as the comorbidity group
*p<0.05
**p<0.01
***p<0.001